ECOG-ACRIN E1912

Primary Category:

Treatment Protocols

Disease Category:

Chronic Lymphocytic Leukemia, Leukemia

Status:

Closed

A Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

 

E1912 closed to accrual  June 9, 2016 at 5:00 pm ET due to reaching its accrual goal.

NCT#02048813

Leave a Reply